Similar articles for PMID: 12017405

Year	Number of Results
1881	1
1992	1
1993	4
1994	1
1995	1
1996	2
1997	6
1998	11
1999	10
2000	9
2001	15
2002	21
2003	14
2004	11
2005	9
2006	2
2007	4
2008	6
2009	4
2010	4
2011	1
2012	4
2013	2
2014	2
2016	1
2017	2
2018	2
2019	9
2020	7
2021	5
2022	7
2023	4
2024	0

1

A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.

Sokol WN Jr, Sullivan JG, Acampora MD, Busman TA, Notario GF. Sokol WN Jr, et al. Clin Ther. 2002 Apr;24(4):605-15. doi: 10.1016/s0149-2918(02)85136-0. Clin Ther. 2002. PMID: 12017405 Clinical Trial.

2

A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.

Gotfried MH, Dattani D, Riffer E, Devcich KJ, Busman TA, Notario GF, Palmer RN. Gotfried MH, et al. Clin Ther. 2002 May;24(5):736-51. doi: 10.1016/s0149-2918(02)85148-7. Clin Ther. 2002. PMID: 12075942 Clinical Trial.

3

Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.

Mathers Dunbar L, Hassman J, Tellier G. Mathers Dunbar L, et al. Clin Ther. 2004 Jan;26(1):48-62. doi: 10.1016/s0149-2918(04)90005-7. Clin Ther. 2004. PMID: 14996517 Clinical Trial.

4

Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization.

Corrêa JC, Badaró R, Bumroongkit C, Mera JR, Dolmann AL, Juárez Martínez LG, Mayrinck LR, Tamez R, Yang JY. Corrêa JC, et al. Clin Ther. 2003 May;25(5):1453-68. doi: 10.1016/s0149-2918(03)80132-7. Clin Ther. 2003. PMID: 12867221 Clinical Trial.

5

Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.

Drehobl MA, De Salvo MC, Lewis DE, Breen JD. Drehobl MA, et al. Chest. 2005 Oct;128(4):2230-7. doi: 10.1378/chest.128.4.2230. Chest. 2005. PMID: 16236879 Clinical Trial.

6

Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.

Lode H, File TM Jr, Mandell L, Ball P, Pypstra R, Thomas M; 185 Gemifloxacin Study Group. Lode H, et al. Clin Ther. 2002 Nov;24(11):1915-36. doi: 10.1016/s0149-2918(02)80088-1. Clin Ther. 2002. PMID: 12501883 Clinical Trial.

7

Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.

Tellier G, Niederman MS, Nusrat R, Patel M, Lavin B. Tellier G, et al. J Antimicrob Chemother. 2004 Aug;54(2):515-23. doi: 10.1093/jac/dkh356. Epub 2004 Jul 21. J Antimicrob Chemother. 2004. PMID: 15269191 Clinical Trial.

8

The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia.

Hoeffken G, Meyer HP, Winter J, Verhoef L; CAP1 Study Group. Hoeffken G, et al. Respir Med. 2001 Jul;95(7):553-64. doi: 10.1053/rmed.2001.1113. Respir Med. 2001. PMID: 11453311 Free article. Clinical Trial.

9

Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Trovafloxacin Chlamydial Urethritis/Cervicitis Study Group.

McCormack WM, Dalu ZA, Martin DH, Hook EW 3rd, Laisi R, Kell P, Pluck ND, Johnson RB. McCormack WM, et al. Sex Transm Dis. 1999 Oct;26(9):531-6. doi: 10.1097/00007435-199910000-00009. Sex Transm Dis. 1999. PMID: 10534208 Clinical Trial.

10

Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.

Gotfried M, Notario G, Spiller J, Palmer R, Busman T. Gotfried M, et al. Curr Med Res Opin. 2005 Feb;21(2):245-54. doi: 10.1185/030079905X26243. Curr Med Res Opin. 2005. PMID: 15801995 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

174 results

Results by year